KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $422,393 | -22.6% | 30,388 | +38.9% | 0.00% | -50.0% |
Q4 2022 | $546,075 | -78.9% | 21,878 | -81.6% | 0.00% | -84.6% |
Q3 2022 | $2,588,000 | +65.7% | 118,881 | +49.9% | 0.01% | +44.4% |
Q2 2022 | $1,562,000 | +83.3% | 79,328 | +447.1% | 0.01% | +350.0% |
Q3 2021 | $852,000 | -64.0% | 14,499 | -70.3% | 0.00% | -77.8% |
Q2 2021 | $2,368,000 | +322.9% | 48,815 | +238.7% | 0.01% | +200.0% |
Q1 2021 | $560,000 | +91.8% | 14,411 | +59.3% | 0.00% | -25.0% |
Q3 2020 | $292,000 | – | 9,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |